Home › Hyperthyroidism › Florida › Miami
Hyperthyroidism clinical trials in Miami, FL
5 studies for Hyperthyroidism are looking for participants at sites in and around Miami (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
RecruitingPhase 3
- Site-061, Miami
A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old
RecruitingPhase 2
- Floridian Clinical Research - Clinitiative, Miami
NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease
RecruitingPhase 1
- Site # 1112, Miami
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
RecruitingPhase 2
- Site Number - 1028, Miami
- Site Number - 1065, Miami
Study of BHV-1300 in Graves' Disease
RecruitingPhase 1
- Site-100, Miami
About Hyperthyroidism
Thyroid hormones control the rate of many activities in your body. Hyperthyroidism means the thyroid makes more thyroid hormones than the body needs.
More about Hyperthyroidism on MedlinePlus
Hyperthyroidism trials in other cities
- Houston, TX5 studies
- Dallas, TX5 studies
- Washington, DC3 studies
- Hialeah, FL3 studies
- Asheville, NC3 studies
- Wilmington, NC3 studies
- Akron, OH3 studies
- San Antonio, TX3 studies
- San Francisco, CA3 studies
- Torrance, CA3 studies
Other studies in Miami
- Breast Cancer42 studies
- Cancer (all types)36 studies
- Non-Small Cell Lung Cancer35 studies
- Prostate Cancer30 studies
- Obesity28 studies
- Ovarian Cancer24 studies
- Acute Myeloid Leukemia24 studies
- Overweight23 studies
- Metastatic Cancer22 studies
- Multiple Myeloma22 studies
- Lung Cancer22 studies
- Alzheimer's Disease21 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.